Neurogene (NGNE) Interest Expenses (2013 - 2026)

Neurogene (NGNE) has 14 years of Interest Expenses data on file, last reported at $7.2 million in Q1 2026.

• Quarterly Interest Expenses rose 928.57% year-over-year to $7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (up 928.57% YoY) and the FY2025 annual result came in at $139.8 million, up 21.57% from the prior year.
• Interest Expenses rose to $7.2 million in Q1 2026, from $226000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $38.2 million in Q4 2022 to a low of $2000.0 in Q4 2024.
• A 5-year average of $6.9 million and a median of $226000.0 in 2025 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses tumbled 99.95% — and 2024, when it soared 1073233.33%.
• Tracing NGNE's Interest Expenses over 5 years: stood at $38.2 million in 2022, then plunged by 99.95% to $19000.0 in 2023, then tumbled by 89.47% to $2000.0 in 2024, then surged by 11200.0% to $226000.0 in 2025, then jumped by 3085.84% to $7.2 million in 2026.
• The last three Interest Expenses figures came in at $7.2 million (Q1 2026), $226000.0 (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.